Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry
- PMID: 34289197
- DOI: 10.1111/jvh.13576
Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry
Keywords: HCV; HIV coinfection; advanced liver disease; late presentation; viral hepatitis.
References
REFERENCES
-
- Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45-S57.
-
- Organization WH. Combating Hepatitis B and C to reach elimination by 2030. http://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief/en/. Accessed September 4, 2018.
-
- Mauss S, Pol S, Buti M, et al. Late presentation of chronic viral hepatitis for medical care: a consensus definition. BMC Med. 2017;15(1):92.
-
- Sanna A, Le Strat Y, Roudot-Thoraval F, et al. Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014. Euro Surveill. 2017;22(30):30582.
-
- Hansen JF, Hallager S, Ovrehus A, Weis N, Brehm Christensen P, Pedersen C. Late presentation for care among patients with chronic hepatitis C: prevalence and risk factors. Open Forum Infect Dis. 2018;5(1):ofx257.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical